{"id":"CHEMBL103","canonicalSmiles":"CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C","inchiKey":"RJKFOVLPORLFTN-LEKSSAKUSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PROGESTERONE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Crinone","Cyclogest","Endometrin","Gesterol","Lutigest","Milprosa","Prochieve","Progesta-care","Progestasert","Progesterone","Progestin","Prometrium","Regumate","Serenity for women","Syngestrone","Utrogestan"],"synonyms":["NSC-64377","NSC-9704","Progesterone","U 3672"],"crossReferences":{"DailyMed":["progesterone"],"PubChem":["144206708","144208990","144210627","17388760","17389514","26719639","26751485","26751486","50104004","50104005","50104007","56424141","75083","855688","90340816"],"Wikipedia":["Progesterone"],"drugbank":["DB00396"],"chEBI":["17026"]},"count":39,"approvedIndications":["EFO_0010269","MONDO_0041161"],"linkedTargets":{"rows":["ENSG00000082175"],"count":1},"linkedDiseases":{"rows":["EFO_0004320","EFO_0007442","EFO_0005204","EFO_0004248","Orphanet_64739","EFO_0002610","EFO_0003869","EFO_0007453","EFO_0000249","MONDO_0007254","EFO_0003768","EFO_0003882","EFO_0002950","EFO_0010141","EFO_0007191","EFO_1000623","HP_0000938","MONDO_0022394","MONDO_0002050","MONDO_0041161","EFO_0000474","EFO_1001375","EFO_0004253","EFO_0000712","EFO_1000645","HP_0008209","EFO_0003917","EFO_0000400","EFO_0004215","EFO_1001491","EFO_0004319","EFO_0000545","HP_0003124","EFO_0008560","EFO_0001645","EFO_0000180","HP_0001657","EFO_0000660","EFO_0000537","EFO_1000954","MP_0001914","EFO_0001072","EFO_0010269","MONDO_0100096","EFO_1000985","EFO_0000731","MONDO_0000831","EFO_0001359","MONDO_0011962","EFO_0000764","EFO_1000237","MONDO_0043510","EFO_0000668","EFO_0003922"],"count":54},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1976 and is indicated for amenorrhea and endometrial hyperplasia and has 37 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL107","canonicalSmiles":"COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2","inchiKey":"IAKHMKGGTNLKSZ-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COLCHICINE","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Colchicine","Colcrys","Gloperba","Mitigare"],"synonyms":["Colchicine","NSC-757"],"crossReferences":{"DailyMed":["colchicine"],"PubChem":["104219585","11114044","144204498","144208745","144210899","170465011","17389095","17389096","26752175","26752176","49718107","50085974","50104821","50104822","50113684","50113685","50113686","67636","90340644"],"TG-GATEs":["113"],"Wikipedia":["Colchicine"],"chEBI":["27882"]},"count":27,"approvedIndications":["EFO_0004274","Orphanet_342"],"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000137285","ENSG00000196230","ENSG00000176014"],"count":9},"linkedDiseases":{"rows":["EFO_0003777","EFO_0000275","EFO_0003780","EFO_0004274","EFO_0000401","MONDO_0001370","EFO_1001129","EFO_1001486","EFO_0006803","EFO_0008585","EFO_0002506","EFO_0005240","EFO_0003884","EFO_0003938","EFO_0000253","EFO_0007427","EFO_0007541","Orphanet_342","EFO_1001404","EFO_0008586","EFO_0000694","EFO_0004269","EFO_0001645","EFO_0003818","MONDO_0008315","EFO_0005221","EFO_0001422","EFO_0004220","MONDO_0100096","EFO_0000270","EFO_0008583","EFO_0000612","EFO_0005672","EFO_0004264"],"count":34},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1961 and is indicated for familial mediterranean fever and gout and has 25 investigational indications."}
{"id":"CHEMBL1079935","canonicalSmiles":"CCNC(=O)N1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1","inchiKey":"NNAIYOXJNVGUOM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMPEROZIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amperozide"],"crossReferences":{"PubChem":["11110766","50110932","90340755"],"Wikipedia":["Amperozide"],"drugbank":["DB08927"]},"childChemblIds":["CHEMBL2092874","CHEMBL1257106"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1087630","canonicalSmiles":"CCCOc1ccc2[nH]c(NC(=O)OC)nc2c1","inchiKey":"RAOCRURYZCVHMG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXIBENDAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Anthelcide eq","Filaribits plus"],"synonyms":["Oxibendazole","SK&F 30310"],"crossReferences":{"PubChem":["104171376","144204395","170465661","174007335","26747039","26747040","50100955","50104165","855911"],"drugbank":["DB04910"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL11266","canonicalSmiles":"O=C(Nc1nc2ccccc2[nH]1)c1cccc(CN2C(=O)N(Cc3cccc(C(=O)Nc4nc5ccccc5[nH]4)c3)[C@H](Cc3ccccc3)[C@H](O)[C@@H](O)[C@H]2Cc2ccccc2)c1","inchiKey":"UWSVAGUSMAEUKO-QHQGJXSCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL11266","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02729"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL112896","canonicalSmiles":"CCCCn1c(Cc2cc(OC)c(OC)c(OC)c2Cl)nc2c(N)ncnc21","inchiKey":"IVPCTHKPOPQMSX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL112896","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03504"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL113","canonicalSmiles":"Cn1c(=O)c2c(ncn2C)n(C)c1=O","inchiKey":"RYYVLZVUVIJVGH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAFFEINE","yearOfFirstApproval":1948,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nodoz","Nodoz caplets and chewable tablets","Pro-plus","Yeast-vite","Zanthine"],"synonyms":["Anhydrous caffeine","Cafcit","Caffeine","Caffeine melting point standard","Coffeine","FEMA NO. 2224","Methyltheobromine","NSC-5036","Theine"],"crossReferences":{"DailyMed":["caffeine","caffeine%20citrate"],"PubChem":["104171124","11110908","124879556","144208883","144210330","17389997","26732615","26752751","49718178","50105397","50105398","90341215"],"TG-GATEs":["97"],"Wikipedia":["Caffeine","Caffeine_(data_page)"],"drugbank":["DB00201"],"chEBI":["27732"]},"childChemblIds":["CHEMBL1200569"],"count":43,"approvedIndications":["EFO_0003888","EFO_0003821","EFO_0003843"],"linkedTargets":{"rows":["ENSG00000282608","ENSG00000170425","ENSG00000128271","ENSG00000163485"],"count":4},"linkedDiseases":{"rows":["MONDO_0004938","EFO_0000729","EFO_0002610","EFO_0000275","EFO_0000249","MONDO_0004567","EFO_1001919","HP_0012228","EFO_0003829","EFO_0003914","EFO_0003925","EFO_0005295","EFO_0000676","EFO_0000253","HP_0003419","HP_0002104","EFO_0003888","EFO_0005296","HP_0012532","EFO_0003035","EFO_0002687","EFO_0003821","EFO_0002508","EFO_0000384","MONDO_0008315","EFO_0005741","HP_0030833","EFO_0005109","HP_0100607","EFO_0001360","EFO_1001158","MONDO_0021107","EFO_0005252","EFO_1001249","EFO_0000274","EFO_0003876","EFO_0000305","Orphanet_68380","EFO_0009444","EFO_0004272","EFO_0003917","EFO_0002617","EFO_0000616","HP_0002094","EFO_0000685","EFO_0001645","MONDO_0001020","EFO_0009692","EFO_0003929","HP_0003418","EFO_0001073","EFO_0003843","HP_0002315","EFO_0007214","EFO_0004220","EFO_0000764","EFO_0001421"],"count":57},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1948 and has 3 approved and 40 investigational indications."}
{"id":"CHEMBL116438","canonicalSmiles":"COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O","inchiKey":"ZIUSSTSXXLLKKK-KOBPDPAPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CURCUMIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CI-75300","Curcumin","Diferuloylmethane","E 100","E-100","E100","INS NO. 100(I)","INS-100(I)","NSC-32982","NSC-687842","Natural Yellow 3"],"crossReferences":{"PubChem":["26749327","50107568","50107570","85148703"],"Wikipedia":["Curcumin"]},"count":44,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 44 investigational indications."}
{"id":"CHEMBL1182210","canonicalSmiles":"CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1","inchiKey":"SIYLLGKDQZGJHK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZETHONIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benzethonium"],"crossReferences":{"PubChem":["104171294","11112266"],"drugbank":["DB11125"]},"childChemblIds":["CHEMBL221753"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1183349","canonicalSmiles":"CNCC(=O)OCc1cccnc1N(C)C(=O)OC(C)[n+]1cnn(C[C@](O)(c2cc(F)ccc2F)[C@@H](C)c2nc(-c3ccc(C#N)cc3)cs2)c1","inchiKey":"RSWOJTICKMKTER-QXLBVTBOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISAVUCONAZONIUM","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["BAL8557-000","Isavuconazonium"],"crossReferences":{"DailyMed":["isavuconazonium%20sulfate"],"drugbank":["DB06636"],"chEBI":["85978"]},"childChemblIds":["CHEMBL3137333","CHEMBL291921","CHEMBL1688829"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2015."}
{"id":"CHEMBL1189432","canonicalSmiles":"CN(C)CC/C=C1/c2ccccc2COc2ccc(CC(=O)O)cc21","inchiKey":"JBIMVDZLSHOPLA-LSCVHKIXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLOPATADINE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Opatanol"],"synonyms":["AL-4943A","Olopatadine"],"crossReferences":{"DailyMed":["olopatadine%20hydrochloride"],"Wikipedia":["Olopatadine"],"drugbank":["DB00768"]},"childChemblIds":["CHEMBL1719"],"count":6,"approvedIndications":["EFO_0005751","HP_0001742"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","HP_0000989","EFO_0007533","EFO_0007141","EFO_0005751","EFO_1001417","HP_0001742","EFO_0003956"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for eye allergy and nasal obstruction and has 4 investigational indications."}
{"id":"CHEMBL1200337","canonicalSmiles":"COCCc1ccc(OCC(O)CNC(C)C)cc1.O=C(O)CCC(=O)O","inchiKey":"ZBOQQGAVXCUYJM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METOPROLOL SUCCINATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL13","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Metoprolol Succinate","Toprol Xl","Toprol-Xl"],"synonyms":["H-93/26"],"crossReferences":{"PubChem":["85273800"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200449","canonicalSmiles":"CC(=O)OCC(=O)[C@@]1(O)[C@H](OC(C)=O)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C","inchiKey":"XGMPVBXKDAHORN-RBWIMXSLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIAMCINOLONE DIACETATE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aristocort","Kenacort","Triamcinolone diacetate"],"synonyms":["Orion","Polcortolon","Tedarol","Triamcinolone 16,21-diacetate","Triamcinolone diacetate"],"crossReferences":{"PubChem":["144206670","170464837"],"chEBI":["9669"]},"count":4,"approvedIndications":["HP_0006536","EFO_0009552","HP_0001742","EFO_0005752"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["HP_0006536","EFO_0009552","HP_0001742","EFO_0005752","EFO_0002950"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and has 4 approved indications."}
{"id":"CHEMBL1200503","canonicalSmiles":"CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CS(=O)(=O)O","inchiKey":"NOJMTMIRQRDZMT-GSPXQYRGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BROMOCRIPTINE MESYLATE","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL493","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bromocriptine mesylate","Cycloset","Parlodel"],"synonyms":["Bromocriptine mesilate","Bromocriptine mesylate","Bromocriptine methanesulfonate","CB-154","CB-154 MESYLATE"],"crossReferences":{"DailyMed":["bromocriptine%20mesylate"],"PubChem":["144213902","442420","50105911"],"chEBI":["3182"]},"count":6,"approvedIndications":["MONDO_0002146","EFO_0000545","EFO_1001485","EFO_0002508","EFO_0007319","EFO_0001360"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000069696","ENSG00000151577"],"count":3},"linkedDiseases":{"rows":["MONDO_0002146","EFO_0000545","EFO_1001485","EFO_0002508","EFO_0007319","EFO_0001360","MONDO_0001299"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and has 6 approved indications."}
{"id":"CHEMBL1200527","canonicalSmiles":"COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1","inchiKey":"XXZSQOVSEBAPGS-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"ATRACURIUM BESYLATE","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1360","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Atracurium Besilate","Atracurium besylate","Atracurium besylate preservative free","Tracrium","Tracrium preservative free"],"synonyms":["Atracurium besilate","Atracurium besylate","BW 33A","BW-33A"],"crossReferences":{"DailyMed":["atracurium%20besylate"],"PubChem":["144204341","174006843"],"drugbank":["DB00732"],"chEBI":["2915"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1983."}
{"id":"CHEMBL1200545","canonicalSmiles":"CC(=O)OCC(=O)[C@@]1(OC(C)=O)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C","inchiKey":"BOBLHFUVNSFZPJ-JOYXJVLSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIFLORASONE DIACETATE","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Diflorasone diacetate","Florone","Florone e","Psorcon","Psorcon e"],"synonyms":["Diflorasone","Diflorasone diacetate","U-34,865","U-34865"],"crossReferences":{"DailyMed":["diflorasone%20diacetate"],"PubChem":["144204426","170465294","29215002","56422226","855657"],"chEBI":["31483"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1977."}
{"id":"CHEMBL1200749","canonicalSmiles":"CCCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C.Cl","inchiKey":"SIEYLFHKZGLBNX-NTISSMGPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOBUPIVACAINE HYDROCHLORIDE","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201193","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chirocaine","Levobupivac"],"synonyms":["Bupivacaine (-)-form hydrochloride","CHIROCAINE","Levobupivacaine hydrochloride"],"crossReferences":{"PubChem":["144205259","170465452"],"chEBI":["31772"]},"count":2,"linkedTargets":{"rows":["ENSG00000007314"],"count":1},"linkedDiseases":{"rows":["EFO_1002012","EFO_0003843","EFO_0000668","EFO_0002950","EFO_0003964"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 2 investigational indications."}
{"id":"CHEMBL1200775","canonicalSmiles":"CC(=O)O.CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1","inchiKey":"RGLRXNKKBLIBQS-XNHQSDQCSA-N","drugType":"Protein","blackBoxWarning":false,"name":"LEUPROLIDE ACETATE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201199","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Carcinil","Eligard","Eligard kit","Fensolvi kit","Leuprolide acetate","Leuprorelin","Lupron","Lupron Depot Ped","Lupron depot","Lupron depot-ped","Lupron depot-ped kit","Lutrate depot kit","Viadur"],"synonyms":["A-43818","ABBOTT-43818","Leuprolide acetate","Leuprolide monoacetate","Leuprorelin acetate","TAP-144"],"crossReferences":{"DailyMed":["leuprolide%20acetate"],"PubChem":["144207056"],"chEBI":["63597"]},"count":21,"approvedIndications":["EFO_0000196","EFO_0000673","EFO_0001663"],"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["EFO_0005204","EFO_0004248","EFO_0003869","Orphanet_64739","EFO_0001065","EFO_0000249","MONDO_0007254","HP_0031217","EFO_1001469","EFO_0002950","HP_0100543","MONDO_0000088","EFO_0000673","EFO_0000196","EFO_0000183","EFO_0000545","MONDO_0019165","EFO_0001073","MONDO_0008315","EFO_0000660","EFO_0001663","EFO_0000537","EFO_0000311","EFO_0009029","EFO_0000731","EFO_0001378","MONDO_0024880","EFO_0003922"],"count":28},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 3 approved and 17 investigational indications."}
{"id":"CHEMBL1200975","canonicalSmiles":"C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@H]1C(=O)COC(=O)C(C)(C)C","inchiKey":"SXYZQZLHAIHKKY-GSTUPEFVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOCORTOLONE PIVALATE","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cloderm"],"synonyms":["Clocortolone 21-pivalate","Clocortolone pivalate","SH 863","SH-863"],"crossReferences":{"DailyMed":["clocortolone%20pivalate"],"PubChem":["144204183","56463639"],"chEBI":["59583"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0000676"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1977."}
{"id":"CHEMBL1201043","canonicalSmiles":"CC(=O)OCC1=C(C(=O)[O-])N2C(=O)[C@@H](NC(=O)CSc3ccncc3)[C@H]2SC1.[Na+]","inchiKey":"VGEOUKPOQQEQSX-OALZAMAHSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CEPHAPIRIN SODIUM","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1599","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cefadyl","Cephapirin sodium"],"synonyms":["BL-P 1322","Cephapirin sodium","Sodium cefapirin"],"crossReferences":{"PubChem":["144204323","170465306","50106036","57261703"],"chEBI":["3545"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1974."}
{"id":"CHEMBL1201565","drugType":"Protein","blackBoxWarning":false,"name":"EPOETIN ALFA","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Binocrit","Epogen","Eprex","Procrit"],"synonyms":["EPO","Epoetin alfa"],"crossReferences":{"DailyMed":["epoetin%20alfa-epbx"],"DrugCentral":["4995"],"Wikipedia":["Epoetin_alfa"]},"count":30,"linkedTargets":{"rows":["ENSG00000187266"],"count":1},"linkedDiseases":{"rows":["EFO_1000172","MONDO_0001240","MONDO_0007254","Orphanet_848","EFO_0009909","EFO_0008585","EFO_0003100","EFO_0000712","EFO_0003884","MONDO_0005299","MONDO_0008903","EFO_0004272","EFO_0003047","HP_0012378","EFO_0003917","HP_0004936","EFO_0000198","EFO_0002618","EFO_0001416","EFO_1001779","EFO_0006859","MONDO_0008170","EFO_0001645","EFO_0000222","Orphanet_95","EFO_0001663","EFO_0000311","EFO_0003890","EFO_0000713","EFO_1001100","EFO_0000764","EFO_0009446","EFO_0000612","MONDO_0043510","EFO_0009492"],"count":35},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1989 and has 30 investigational indications."}
{"id":"CHEMBL1201655","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN SUSP ISOPHANE PURIFIED BEEF","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nph iletin ii"],"synonyms":["Insulin susp isophane purified beef"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1980."}
{"id":"CHEMBL1201661","drugType":"Protein","blackBoxWarning":false,"name":"CALCITONIN SALMON RECOMBINANT","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fortical"],"synonyms":["Calcitonin (salmon synthetic)","Calcitonin salmon recombinant"],"crossReferences":{"DailyMed":["calcitonin%20salmon%20recombinant"]},"count":4,"approvedIndications":["EFO_0003854","EFO_0005754"],"linkedTargets":{"rows":["ENSG00000004948"],"count":1},"linkedDiseases":{"rows":["HP_0000938","EFO_0003854","EFO_0003882","EFO_0005754"],"count":4},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and is indicated for parathyroid disease and postmenopausal osteoporosis and has 2 investigational indications."}
{"id":"CHEMBL1201780","canonicalSmiles":"NC(=O)N[C@@H](CCC(=O)O)C(=O)O","inchiKey":"LCQLHJZYVOQKHU-VKHMYHEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARGLUMIC ACID","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Carbaglu"],"synonyms":["Carglumic acid","OE 312","OE 312 (LABORATORY CODE DESIGNATION)","OE-312"],"crossReferences":{"DailyMed":["carglumic%20acid"],"PubChem":["144206097","170466164"],"Wikipedia":["Carglumic_acid"],"drugbank":["DB06775"],"chEBI":["71028"]},"count":3,"approvedIndications":["Orphanet_927"],"linkedTargets":{"rows":["ENSG00000021826"],"count":1},"linkedDiseases":{"rows":["MONDO_0002012","Orphanet_35","Orphanet_68367","Orphanet_927"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and is indicated for hyperammonemia due to n-acetylglutamate synthetase deficiency and has 2 investigational indications."}
{"id":"CHEMBL120643","canonicalSmiles":"CC(C)=CCC/C(C)=C/CC/C(C)=C/CCC1(C)CCc2cc(O)ccc2O1","inchiKey":"GJJVAFUKOBZPCB-ZGRPYONQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL120643","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["124897770"],"drugbank":["DB12647"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1213252","canonicalSmiles":"O=C(O)C1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O","inchiKey":"XDDJGVMJFWAHJX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CLORAZEPIC ACID","yearOfFirstApproval":1972,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["4306-CB FREE ACID","ABBOTT-35616 FREE ACID","Clorazepate","Clorazepic acid"],"crossReferences":{"DailyMed":["clorazepate%20dipotassium"],"drugbank":["DB00628"],"chEBI":["3761"]},"childChemblIds":["CHEMBL2096631","CHEMBL2106085"],"linkedTargets":{"rows":["ENSG00000182256","ENSG00000022355","ENSG00000011677","ENSG00000113327","ENSG00000151834","ENSG00000163285","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["MONDO_0002050","EFO_0005230"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1972. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1214","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)O)c3ccccc3)C(=O)N2[C@H]1C(=O)O","inchiKey":"FPPNZSSZRUTDAP-UWFZAAFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBENICILLIN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Carbenicillin","Geocillin","Geopen","Pyopen"],"crossReferences":{"Wikipedia":["Carbenicillin"],"drugbank":["DB00578"],"chEBI":["3393"]},"childChemblIds":["CHEMBL2105992","CHEMBL606260"],"count":2,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL1229651","canonicalSmiles":"Cc1cccc2c1C(=O)N(c1ccnc(Cl)c1)C2=O","inchiKey":"YDJMWNHJNJVVMM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1229651","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06860"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1229656","canonicalSmiles":"C[N+](C)(C)C[C@H](O)CC(=O)O","inchiKey":"PHIQHXFUZVPYII-ZCFIWIBFSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXTROCARNITINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02648"],"chEBI":["39547"]},"childChemblIds":["CHEMBL1876404"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231649","canonicalSmiles":"CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)C(=O)/C=C/[C@@H]2O[C@H]2C[C@@H](C)OC(=O)C[C@H]1OC(C)=O","inchiKey":"FQVHOULQCKDUCY-OGHXVOSASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBOMYCIN A","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB11383"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232369","canonicalSmiles":"NC(=O)C[C@@H](N)C(=O)O","inchiKey":"DCXYFEDJOCDNAF-UWTATZPHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232369","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26756685"],"drugbank":["DB03943"],"chEBI":["28159"]},"childChemblIds":["CHEMBL2361922"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233749","canonicalSmiles":"C#CCN1CCN(c2c(Cl)cccc2NC(=O)c2ccc(Br)o2)CC1","inchiKey":"MEFJFXHHHNDHEN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233749","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08021"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233795","canonicalSmiles":"COc1ccc2ccccc2c1/C=N/NC(=O)c1ccc(O)c(O)c1","inchiKey":"TVOPERZEGKBKAY-RGVLZGJSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233795","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08034"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234952","canonicalSmiles":"CCCCCCCCN[C@@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"UPZUHYMBTUUPML-KBXIAJHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"N-Octylvalienamine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["N-Octylvalienamine"],"crossReferences":{"drugbank":["DB08321"]},"childChemblIds":["CHEMBL1922580"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235529","canonicalSmiles":"O=S1(=O)NCCCNc2nc(ncc2Br)Nc2cccc1c2","inchiKey":"AWSQADBSXFTFKL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235529","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08441"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236395","canonicalSmiles":"OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"HDTRYLNUVZCQOY-LIZSDCNHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TREHALOSE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-2093","Trehalose"],"crossReferences":{"Wikipedia":["Trehalose"],"drugbank":["DB12310"],"chEBI":["16551"]},"childChemblIds":["CHEMBL3188936"],"count":5,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1236544","canonicalSmiles":"CC(=O)N[C@H]1[C@@H](OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)[C@H](O)[C@@H]2O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@@](C)(OP(=O)(O)O)C(=O)O","inchiKey":"NLBIPGBVVPCESQ-BVDGEXFOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1236544","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04174"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL123978","canonicalSmiles":"COc1cccc(C(N)=O)c1","inchiKey":"VKPLPDIMEREJJF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-Methoxy-Benzamide","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-Methoxy-Benzamide","3-Methoxybenzamide"],"crossReferences":{"PubChem":["47193707"],"drugbank":["DB03073"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1240772","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C","inchiKey":"UCZDWGAJSOUHOU-VDBPWWIZSA-N","drugType":"Protein","blackBoxWarning":false,"name":"GLP-1","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Glp-1"],"count":6,"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL1255","canonicalSmiles":"C=O","inchiKey":"WSFSSNUMVMOOMR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FORMALDEHYDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dowling's","Veracur"],"synonyms":["E240","Formaldehyde","Formaldehyde solution","Formalin","NSC-298885"],"crossReferences":{"PubChem":["144212755"],"Wikipedia":["Formaldehyde"],"drugbank":["DB03843"],"chEBI":["16842"]},"childChemblIds":["CHEMBL4285219"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1257070","canonicalSmiles":"Cc1oc(=O)oc1COC(=O)C1=C([C@H]2CCCO2)S[C@@H]2[C@@H]([C@@H](C)O)C(=O)N12","inchiKey":"JQBKWZPHJOEQAO-DVPVEWDBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FAROPENEM MEDOXOMIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-0026","A0026","BAY-56-6854","Faropenem daloxate","Faropenem medoxomil","SUN-A0026"],"crossReferences":{"drugbank":["DB05659"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1263","canonicalSmiles":"OCc1cc(C(O)CNCCCCCCOCCCCc2ccccc2)ccc1O","inchiKey":"GIIZNNXWQWCKIB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"SALMETEROL","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Beglan","Neovent","Serevent","Soltel","Vertine"],"synonyms":["GR 33343 X","GR-33343-X","GR-33343X","SN408D","Salmaterol","Salmeterol","Serevent"],"crossReferences":{"DailyMed":["salmeterol%20xinafoate"],"PubChem":["144207133","26719802"],"Wikipedia":["Salmeterol"],"drugbank":["DB00938"],"chEBI":["64064"]},"childChemblIds":["CHEMBL3126379","CHEMBL1082607"],"count":6,"approvedIndications":["HP_0006536"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","HP_0006536","EFO_0007183","EFO_0000270","EFO_0000464","EFO_0006505","EFO_1001919","EFO_0010638","EFO_0000341","HP_0025428","EFO_0001073"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and is indicated for airway obstruction and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1319139","canonicalSmiles":"CN(Cc1cc(Br)cc(Br)c1N)C1CCCCC1.Cl","inchiKey":"UCDKONUHZNTQPY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BROMHEXINE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL253376","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bisolvon"],"synonyms":["Brombenzonium","Bromhexine hydrochloride","NA 274","NA-274"],"crossReferences":{"PubChem":["144204938","170465803","26748706"],"chEBI":["31303"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1364551","canonicalSmiles":"Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1.Cl.Cl","inchiKey":"GNUCGROXDZMCJI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MINAPRINE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL278819","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["France"],"classes":["Neurotoxicity"],"year":1996},"tradeNames":["Cantor"],"synonyms":["30038CB","Minaprine hydrochloride"],"crossReferences":{"PubChem":["144204908","170466172","26748498"],"chEBI":["51040"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in France  in 1996 due to Neurotoxicity."}
{"id":"CHEMBL1364906","canonicalSmiles":"O=C(NC(=O)c1c(F)cccc1F)Nc1cc(Cl)c(OC(F)(F)C(F)C(F)(F)F)cc1Cl","inchiKey":"PWPJGUXAGUPAHP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LUFENURON","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lufenuron"],"crossReferences":{"PubChem":["144205095","144211224","170465736","26749995","26753780"],"drugbank":["DB11424"],"chEBI":["39384"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1396398","canonicalSmiles":"Cl.O.Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314","inchiKey":"IUGXDRGXUYNFHK-XSFMULHUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1396398","maximumClinicalTrialPhase":0,"parentId":"CHEMBL895","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["56320910"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL146624","canonicalSmiles":"CCc1ccc(C(=O)COc2ccc(CC3SC(=O)NC3=O)cc2)nc1","inchiKey":"IRNJSRAGRIZIHD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MITOGLITAZONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CAY-10415","J730.386F","MSD-9","MSDC-0160","Mitoglitazone","PNU-91325","U-91325"],"crossReferences":{"drugbank":["DB11721"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL146972","canonicalSmiles":"NCCOP(=O)(O)O","inchiKey":"SUHOOTKUPISOBE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHOSPHORYLETHANOLAMINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-254167","Phosphorylcolamine","Phosphorylethanolamine"],"crossReferences":{"Wikipedia":["Phosphorylethanolamine"],"drugbank":["DB01738"],"chEBI":["17553"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1472","canonicalSmiles":"NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1","inchiKey":"XNSAINXGIQZQOO-SRVKXCTJSA-N","drugType":"Protein","blackBoxWarning":false,"name":"PROTIRELIN","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Thypinone","Thyrel trh","Trh-cambridge"],"synonyms":["A-38579","ABBOTT-38579","Lopremone","Protirelin","Protirelin tartrate","SYNTHETIC TRH","Synthetic TRH"],"crossReferences":{"PubChem":["144205492","29216304"],"Wikipedia":["Thyrotropin-releasing_hormone"],"drugbank":["DB09421"],"chEBI":["35940"]},"count":2,"linkedTargets":{"rows":["ENSG00000174417"],"count":1},"linkedDiseases":{"rows":["EFO_1000637","EFO_0000311"],"count":2},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1976 and has 2 investigational indications."}
{"id":"CHEMBL147792","canonicalSmiles":"CC[C@@]1(C(=O)N[C@H](C)c2ccc(Cl)cc2)[C@@H](C)C1(Cl)Cl","inchiKey":"RXDMAYSSBPYBFW-RULNRJAQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARPROPAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02946"],"chEBI":["47351"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1530428","canonicalSmiles":"CC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C","inchiKey":"AKUJBENLRBOFTD-RPRRAYFGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXAMETHASONE ACETATE","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Decadron","Decadron-la","Dexamethasone acetate"],"synonyms":["Dexamethasone 21-acetate","Dexamethasone acetate","Dexamethasone acetate monohydrate","NSC-39471"],"crossReferences":{"PubChem":["144204050","144206481","170466872","56423129","855773"],"drugbank":["DB14649"],"chEBI":["4463"]},"count":9,"approvedIndications":["EFO_0009552","EFO_0003894","HP_0001742","EFO_0005752"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["MONDO_0021108","EFO_0002426","HP_0001742","EFO_0003894","HP_0002018","EFO_0000565","EFO_0003931","EFO_1001216","EFO_1000652","EFO_0000574","EFO_0009552","HP_0002013","EFO_0001378","EFO_0005752"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1973 and has 4 approved and 5 investigational indications."}
{"id":"CHEMBL1557","canonicalSmiles":"Cl.NCCc1ccc(O)c(O)c1","inchiKey":"CTENFNNZBMHDDG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOPAMINE HYDROCHLORIDE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL59","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dopamin-Natterman","Dopamine hydrochloride","Dopmin","Dynatra","Intropin","Sabax Dopamin","Selectajet"],"synonyms":["ASL-279","Dopamine hydrochloride","NSC-169105"],"crossReferences":{"DailyMed":["dopamine%20hydrochloride"],"PubChem":["11532883","144208216","26747527","26747528","50106387","50106388","56424030"]},"count":1,"linkedTargets":{"rows":["ENSG00000043591"],"count":1},"linkedDiseases":{"rows":["EFO_0002508","EFO_0003144"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1974 and has 1 investigational indication."}
{"id":"CHEMBL1596440","canonicalSmiles":"CN(C)CCC(c1ccccc1)c1ccccn1.O=C(O)/C=C/C(=O)O","inchiKey":"SSOXZAQUVINQSA-WLHGVMLRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1596440","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1193","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11532876"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1607480","canonicalSmiles":"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12.Cl","inchiKey":"UBDNTYUBJLXUNN-IFLJXUKPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYTETRACYCLINE HYDROCHLORIDE","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1517","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Oxy-kesso-tetra","Oxytetracycline hydrochloride","Terramycin"],"synonyms":["Oxytetracycline hydrochloride"],"crossReferences":{"PubChem":["144204660","144209048","144210918","17389774","26757862"],"chEBI":["31953"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1964 and has 1 investigational indication."}
{"id":"CHEMBL1619528","canonicalSmiles":"CC[N+]1(C)CCCC(OC(=O)C(O)(c2ccccc2)c2ccccc2)C1","inchiKey":"WPUKUEMZZRVAKZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPENZOLATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Pipenzolate"],"crossReferences":{"Wikipedia":["Pipenzolate"],"drugbank":["DB13844"]},"childChemblIds":["CHEMBL1401367"],"count":1,"approvedIndications":["EFO_0010282"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for gastrointestinal disease."}
{"id":"CHEMBL1628","canonicalSmiles":"N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1.O=C(O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO","inchiKey":"KUXUALPOSMRJSW-IFWQJVLJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORHEXIDINE GLUCONATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL790","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Bioscrub","Brian Care","Chg Scrub","Chlorhexidine Gluconate","Cida-Stat","Dyna-Hex","E-Z Scrub","Exidine","Hibiclens","Microderm","Peridex","Periochip","Periogard","Pharmaseal Scrub Care","Prevacare R","Steri-Stat"],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL167150","canonicalSmiles":"COP(=O)(OC)C(O)C(Cl)(Cl)Cl","inchiKey":"NFACJZMKEDPNKN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRICHLORFON","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bilarcil"],"synonyms":["BAYER L 1359","DETF","Metrifonate","Metriphonate","Trichlorfon"],"crossReferences":{"PubChem":["104171375","144204394","144208805","144211177","170465707","26752327","855564"],"drugbank":["DB11473"],"chEBI":["6908"]},"count":1,"approvedIndications":["EFO_1001342"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for helminthiasis."}
{"id":"CHEMBL1697759","canonicalSmiles":"O=C(NCN1CCOCC1)c1cnccn1","inchiKey":"GVTLAVKAVSKBKK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MORINAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["B-2311","Morinamide","Morphazinamide"],"crossReferences":{"PubChem":["144205376","170466494","50085443"],"drugbank":["DB13417"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1697762","canonicalSmiles":"O=C(OCC(COC(=O)c1cccnc1)(COC(=O)c1cccnc1)COC(=O)c1cccnc1)c1cccnc1","inchiKey":"KUEUWHJGRZKESU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NICERITROL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Niceritrol"],"crossReferences":{"PubChem":["170465789"],"drugbank":["DB13441"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL171148","canonicalSmiles":"O=C1N(Cc2ccccc2)[C@H](COc2ccccc2)[C@H](O)[C@@H](O)[C@@H](COc2ccccc2)N1Cc1ccccc1","inchiKey":"SQBOSZXDOHQFAA-ZRTHHSRSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL171148","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01732"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1743039","drugType":"Antibody","blackBoxWarning":false,"name":"MAVRILIMUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CAM-3001","CAM3001","Mavrilimumab"],"count":1,"linkedTargets":{"rows":["ENSG00000198223","ENSG00000100368"],"count":2},"linkedDiseases":{"rows":["EFO_1001209","EFO_0000685","MONDO_0100096"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1795072","drugType":"Protein","blackBoxWarning":true,"name":"ZICONOTIDE ACETATE","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Prialt"],"synonyms":["Ziconotide acetate"],"crossReferences":{"DailyMed":["ziconotide%20acetate"]},"count":2,"approvedIndications":["HP_0001945","EFO_0003843"],"linkedTargets":{"rows":["ENSG00000148408"],"count":1},"linkedDiseases":{"rows":["HP_0001945","EFO_0003843"],"count":2},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for fever and pain. This drug has a black box warning from the FDA."}
{"id":"CHEMBL180454","canonicalSmiles":"CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1.O=C(O)/C=C/C(=O)O","inchiKey":"DBAKFASWICGISY-WLHGVMLRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORPHENAMINE MALEATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL505","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11533013"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL18116","canonicalSmiles":"Cc1cccc(N2CC(CO)OC2=O)c1","inchiKey":"MXUNKHLAEDCYJL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOLOXATONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Toloxatone"],"crossReferences":{"Wikipedia":["Toloxatone"],"drugbank":["DB09245"]},"count":1,"linkedTargets":{"rows":["ENSG00000189221"],"count":1},"linkedDiseases":{"rows":["EFO_0003761"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1852164","canonicalSmiles":"C/C(=N\\O)c1nc([C@@H](O)[C@H](O)[C@H](O)CO)c[nH]1","inchiKey":"AMXVYJYMZLDINS-RSWLNLDNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LX-2931","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LX 2931","LX-3305","LX2931","LX3305","Lx-2931","Lx3305"],"crossReferences":{"drugbank":["DB06297"]},"childChemblIds":["CHEMBL1802099"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL186","canonicalSmiles":"CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[N+]3(C)CCCC3)CS[C@H]12)c1csc(N)n1","inchiKey":"HVFLCNVBZFFHBT-ZKDACBOMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFEPIME","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Maxipime","Renapime"],"synonyms":["BMY-28142","Cefepime","J01DE01","VNRX-5022"],"crossReferences":{"DailyMed":["cefepime%20hydrochloride"],"Wikipedia":["Cefepime"],"drugbank":["DB01413"],"chEBI":["478164"]},"childChemblIds":["CHEMBL1201736","CHEMBL1200962"],"count":8,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for bacterial disease and has 7 investigational indications."}
{"id":"CHEMBL1906890","canonicalSmiles":"CC[C@H]1CN2CCC1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12","inchiKey":"LJOQGZACKSYWCH-NBGVHYBESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROQUINIDINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hydroquinidine"],"crossReferences":{"chEBI":["5792"]},"childChemblIds":["CHEMBL1893843"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1908391","canonicalSmiles":"Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1","inchiKey":"WJEOLQLKVOPQFV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MASITINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Kinavet","Masivet"],"synonyms":["AB-1010","Ab-1010","Masitinib"],"crossReferences":{"PubChem":["124950163","99460877"],"drugbank":["DB11526"],"chEBI":["63450"]},"count":16,"linkedTargets":{"rows":["ENSG00000134853","ENSG00000068078","ENSG00000157404","ENSG00000113721"],"count":4},"linkedDiseases":{"rows":["EFO_0002618","EFO_0000616","EFO_0000685","EFO_0000249","MONDO_0008170","Orphanet_44890","MONDO_0016586","EFO_0009001","MONDO_0008315","EFO_0003885","EFO_1001480","EFO_0003840","MONDO_0100096","EFO_0000270","EFO_0000676","EFO_0000253","EFO_0001378","EFO_0002617"],"count":18},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 16 investigational indications."}
{"id":"CHEMBL1927030","canonicalSmiles":"CN[C@H](C)Cc1ccccc1","inchiKey":"MYWUZJCMWCOHBA-SECBINFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVMETAMFETAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-desoxyephedrine","Levmetamfetamine"],"crossReferences":{"drugbank":["DB09571"]},"childChemblIds":["CHEMBL3189065"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1952141","canonicalSmiles":"CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1.O=S(=O)(O)O","inchiKey":"SWWUERNOFRFXQM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1952141","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1952329","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2089125","canonicalSmiles":"N=C(N)NCCC[C@H](N)C(=O)c1nc2ccccc2s1","inchiKey":"MAJHCCQPIDXPAN-QMMMGPOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2089125","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08624"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2096629","drugType":"Small molecule","blackBoxWarning":false,"name":"PRUSSIAN BLUE INSOLUBLE","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Antidotum-thallii-heyl","Radiogardase (prussian blue)","Radiogardase-cs"],"synonyms":["Ferric Hexacyanoferrate(II)","Ferric hexacyanoferrate(ii)","Prussian Blue","Prussian blue","Prussian blue insoluble"],"crossReferences":{"DrugCentral":["4860"],"Wikipedia":["Prussian_blue"],"chEBI":["30069"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2003."}
{"id":"CHEMBL2103810","canonicalSmiles":"CCOC(=O)[C@@H](N)CCC(=O)N[C@@H](CSCc1ccccc1)C(=O)N[C@@H](C(=O)OCC)c1ccccc1.Cl","inchiKey":"XJDYQYNYISTAMO-GFDYFVENSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EZATIOSTAT HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2110585","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Telintra"],"synonyms":["Ezatiostat hydrochloride","TER-199","TER199","TLK-199 HYDROCHLORIDE","TLK199"],"count":2,"linkedTargets":{"rows":["ENSG00000084207"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","MONDO_0001475","EFO_0003060"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2104153","canonicalSmiles":"CC(CN(C)C)CN1c2ccccc2Sc2ccc(C#N)cc21","inchiKey":"SLFGIOIONGJGRT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYAMEMAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cyamemazine","Cyamepromazine","Kyamepromazin","RP 7204"],"crossReferences":{"drugbank":["DB09000"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104254","canonicalSmiles":"CCOC(=O)C1(c2ccccc2)CCN(CCOCCO)CC1","inchiKey":"KJTKYGFGPQSRRA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETOXERIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Etoxeridine","UCB 2073","WY-2039"],"crossReferences":{"drugbank":["DB01505"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104264","canonicalSmiles":"CCN(CC)CCn1cnc2c1c(=O)n(C)c(=O)n2C","inchiKey":"AWKLBIOQCIORSB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETAMIPHYLLIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dietamiphylline","Etamiphyllin","Etamiphylline"],"crossReferences":{"drugbank":["DB13592"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104619","canonicalSmiles":"Cc1nc2c(C)cccn2c(=O)c1CCN1CCC(c2noc3cc(F)ccc23)CC1","inchiKey":"ZZQNEJILGNNOEP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OCAPERIDONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ocaperidone","R 79598"],"crossReferences":{"drugbank":["DB06229"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104722","canonicalSmiles":"N=C(NC(=N)N1CCN(C(=N)NC(=N)Nc2ccc(Cl)cc2)CC1)Nc1ccc(Cl)cc1","inchiKey":"YNCLPFSAZFGQCD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PICLOXYDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Picloxydine"],"crossReferences":{"drugbank":["DB13607"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104895","canonicalSmiles":"CN1CCC2=C(C1)c1ccccc1Cc1ccccc12","inchiKey":"GVPIXRLYKVFFMK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SETIPTILINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Setiptiline","Setiptiline maleate"],"crossReferences":{"drugbank":["DB09304"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105717","canonicalSmiles":"COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC","inchiKey":"ONIQOQHATWINJY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CABOZANTINIB","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cabometyx","Cometriq"],"synonyms":["BMS-907351","BMS-907351 FREE BASE","Cabozantinib","XL-184","XL-184 FREE BASE","XL184"],"crossReferences":{"DailyMed":["cabozantinib%20s-malate"],"PubChem":["137276008"],"drugbank":["DB08875"],"chEBI":["72317"]},"childChemblIds":["CHEMBL2103868"],"count":39,"approvedIndications":["EFO_0000616","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000128052","ENSG00000105976"],"count":2},"linkedDiseases":{"rows":["EFO_1000592","EFO_0000756","EFO_0000681","EFO_1001951","MONDO_0002974","EFO_0000182","EFO_0000501","EFO_0008528","EFO_0000641","MONDO_0015277","MONDO_0018352","EFO_0002618","MONDO_0002108","EFO_0000349","EFO_1001512","MONDO_0004669","EFO_1001968","MONDO_0008315","EFO_1000489","EFO_0000335","EFO_0008524","EFO_1000613","EFO_0001378","EFO_1000796","EFO_0000563","EFO_0003016","EFO_0000292","EFO_1001901","EFO_1001465","MONDO_0007254","MONDO_0024879","EFO_0000272","MONDO_0001187","EFO_1000044","EFO_0003968","EFO_1001974","EFO_0000673","EFO_0000326","EFO_0002499","EFO_0000707","EFO_0000239","EFO_0002617","EFO_0002914","EFO_0000616","EFO_1000616","EFO_1000603","Orphanet_44890","EFO_0000222","EFO_0004243","EFO_0003060","EFO_0000311","EFO_1001961","EFO_0000640","EFO_0003863","MONDO_0002120","EFO_0002892","EFO_0001421","EFO_0000519"],"count":58},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and is indicated for cancer and neoplasm and has 37 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2105731","canonicalSmiles":"Cc1cc(-c2ccccc2[C@@H](C)OC[C@H](O)CNC(C)(C)Cc2ccc(Cl)c(F)c2)ccc1C(=O)O.Cc1cc(-c2ccccc2[C@@H](C)OC[C@H](O)CNC(C)(C)Cc2ccc(Cl)c(F)c2)ccc1C(=O)O.O.O=S(=O)(O)O","inchiKey":"NOJBHZIZNPMQRT-CBASKZFISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENCALERET SULFATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL1672973","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Encaleret sulfate","MK-5442","MK5442","Mk-5442"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2106006","canonicalSmiles":"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@](C)(O)[C@H]3C[C@@H]12.O=S(=O)(O)O","inchiKey":"GQUMQTDURIYYIA-MRFRVZCGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORTETRACYCLINE BISULFATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL404520","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chlortetracycline bisulfate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106530","canonicalSmiles":"O=C(N/N=C/C=C/c1ccc([N+](=O)[O-])o1)c1ccc([N+](=O)[O-])s1","inchiKey":"IDUMOVRJNBNOTR-BIZLIJPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIFURZIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nifurzide"],"crossReferences":{"drugbank":["DB13325"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108672","drugType":"Antibody","blackBoxWarning":false,"name":"VORSETUZUMAB MAFODOTIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Sgn-75"],"synonyms":["SGN-75","Vorsetuzumab mafodotin"],"count":1,"linkedTargets":{"rows":["ENSG00000125726"],"count":1},"linkedDiseases":{"rows":["EFO_0000681"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2108713","drugType":"Antibody","blackBoxWarning":false,"name":"IODINE I 124 GIRENTUXIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Redectane"],"synonyms":["124ICG250","Iodine (124i) girentuximab","Iodine i 124 girentuximab","cG250 (124I)"],"linkedTargets":{"rows":["ENSG00000107159"],"count":1},"linkedDiseases":{"rows":["EFO_0000681","MONDO_0002367"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2108792","drugType":"Protein","blackBoxWarning":false,"name":"TIFACOGIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LAC-I","LACI","SC-59735","Tifacogin"],"count":1,"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2109355","drugType":"Antibody","blackBoxWarning":false,"name":"DUSIGITUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dusigitumab","MEDI-573","MEDI573"],"count":3,"linkedTargets":{"rows":["ENSG00000167244","ENSG00000017427"],"count":2},"linkedDiseases":{"rows":["EFO_0000182","MONDO_0007254","EFO_0000311"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2109447","drugType":"Antibody","blackBoxWarning":false,"name":"LYM-1","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Oncolym"],"synonyms":["LYM-1","Lym-1"],"count":1,"linkedTargets":{"rows":["ENSG00000196126"],"count":1},"linkedDiseases":{"rows":["EFO_0000574"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2109514","drugType":"Antibody","blackBoxWarning":false,"name":"PTI-6D2","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PTI-6D2"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109613","drugType":"Antibody","blackBoxWarning":false,"name":"PF-04236921","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF 4236921","PF-04236921","PF-4236921","Pf-04236921"],"count":2,"linkedTargets":{"rows":["ENSG00000136244"],"count":1},"linkedDiseases":{"rows":["EFO_0002690","EFO_0000384"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109622","drugType":"Antibody","blackBoxWarning":false,"name":"PF-04605412","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-04605412","Pf-04605412"],"count":1,"linkedTargets":{"rows":["ENSG00000161638"],"count":1},"linkedDiseases":{"rows":["EFO_0000311"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2110368","canonicalSmiles":"C/N=C(\\NC)NCc1ccccc1.C/N=C(\\NC)NCc1ccccc1.O=S(=O)(O)O","inchiKey":"YTIJUXVIZLYQTB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETHANIDINE SULFATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201260","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bendogen","Esbatal","Tenathan"],"synonyms":["BW-467-C-60","Betanidine sulfate","Bethanidine sulfate"],"crossReferences":{"chEBI":["31279"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL2110732","canonicalSmiles":"COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1","inchiKey":"LVXJQMNHJWSHET-AATRIKPKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DACOMITINIB","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dacomitinib","Dacomitinib hydrate","Pf-00299804"],"crossReferences":{"DailyMed":["dacomitinib"],"drugbank":["DB11963"]},"childChemblIds":["CHEMBL2105719"],"count":14,"approvedIndications":["EFO_0000616"],"linkedTargets":{"rows":["ENSG00000146648","ENSG00000178568","ENSG00000141736"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000313","EFO_0003060","EFO_1001951","EFO_0009708","EFO_0005570","MONDO_0008903","EFO_0001421","MONDO_0001657","EFO_0004284","EFO_1001094","EFO_0000707","EFO_0000181","EFO_0000519"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for neoplasm and has 13 investigational indications."}
{"id":"CHEMBL2110788","canonicalSmiles":"CC[N+]1(CC)CCC(OC(=O)C(O)(c2ccccc2)c2ccccc2)C1","inchiKey":"ZKCWITXZGWUJAV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZILONIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benzilone"],"crossReferences":{"drugbank":["DB13369"]},"childChemblIds":["CHEMBL2106061"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL212301","canonicalSmiles":"N=C(N)NCCC[C@@H](N)C(=O)O","inchiKey":"ODKSFYDXXFIFQN-SCSAIBSYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"D-Arginine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D-Arginine"],"crossReferences":{"PubChem":["26754410","26754411"],"Wikipedia":["Arginine"],"drugbank":["DB04027"],"chEBI":["15816"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2131134","canonicalSmiles":"CO.COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl","inchiKey":"KBLGKECLADKUHT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2131134","maximumClinicalTrialPhase":0,"parentId":"CHEMBL288441","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144207149","170466788"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2146110","canonicalSmiles":"Cl.Fc1ccc(-c2cncc(CNC[C@H]3CCc4ccccc4O3)c2)cc1","inchiKey":"QDLVYMYXOLGZOD-ZMBIFBSDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SARIZOTAN HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL220808","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EMD 128130","EMD-128130","Emd128130","Sarizotan hydrochloride"],"count":2,"linkedTargets":{"rows":["ENSG00000178394","ENSG00000149295","ENSG00000069696","ENSG00000151577"],"count":4},"linkedDiseases":{"rows":["EFO_0004280","EFO_0002508"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2151572","canonicalSmiles":"O=C(N[C@H]1CN2CCC1CC2)c1cc2cccc(Cl)c2s1","inchiKey":"SSRDSYXGYPJKRR-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENCENICLINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EVP-6124","Encenicline","Evp-6124","MT-4666","MT4666"],"crossReferences":{"drugbank":["DB11726"]},"childChemblIds":["CHEMBL3137323"],"count":6,"linkedTargets":{"rows":["ENSG00000175344"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","HP_0000726","EFO_0000249","EFO_0001421","EFO_0005411","EFO_0000692"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2219418","canonicalSmiles":"C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](OCCOCCOCCOCCOCCOCCOCCOC)CC[C@@]3(O)[C@H]1C5","inchiKey":"XNKCCCKFOQNXKV-ZRSCBOBOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NALOXEGOL","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Moventig"],"synonyms":["AZ-13337019","NKTR-118","Naloxegol"],"crossReferences":{"DailyMed":["naloxegol%20oxalate"],"drugbank":["DB09049"],"chEBI":["82975"]},"childChemblIds":["CHEMBL2219416"],"count":3,"approvedIndications":["HP_0002019"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["MONDO_0004567","EFO_0005611","EFO_0003843","EFO_0003060","HP_0002019"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for constipation and has 2 investigational indications."}
{"id":"CHEMBL222440","canonicalSmiles":"O=C(O)c1cc(Oc2ccc(C(F)(F)F)cc2Cl)ccc1[N+](=O)[O-]","inchiKey":"NUFNQYOELLVIPL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACIFLUORFEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acifluorfen"],"crossReferences":{"PubChem":["144209037","144211077","26757299","29216446","47193733"],"Wikipedia":["Acifluorfen"],"drugbank":["DB07338"],"chEBI":["73172"]},"childChemblIds":["CHEMBL3184255"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL225983","canonicalSmiles":"O=C(O)[C@@H](O)[C@@H](O)C(=O)O","inchiKey":"FEWJPZIEWOKRBE-XIXRPRMCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(2S,3R)-2,3-Dihydroxysuccinic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(2S,3R)-2,3-Dihydroxysuccinic Acid","Meso-Tartrate"],"crossReferences":{"drugbank":["DB14756"],"chEBI":["15673"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2312181","canonicalSmiles":"CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4)oc23)C1CO","inchiKey":"HRTOUPQLDWWXIX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"P-276-00","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["P 276-00","P-276-00","P-27600"],"count":7,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL23254","canonicalSmiles":"CC(C)[C@H](CO)Nc1nc(Nc2ccc(C(=O)O)c(Cl)c2)c2ncn(C(C)C)c2n1","inchiKey":"ZKDXRFMOHZVXSG-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PURVALANOL B","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11114141"],"drugbank":["DB02733"],"chEBI":["49840"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL232566","canonicalSmiles":"O=C(NCCNC(=O)c1ccc(Cl)s1)c1ccc(-n2ccccc2=O)cc1","inchiKey":"UCKHUNHXYMAFQM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL232566","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08173"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL240163","canonicalSmiles":"C[C@H]1COc2c(C3(N)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23","inchiKey":"XAGMUUZPGZWTRP-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PAZUFLOXACIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pazufloxacin","T-3761"],"crossReferences":{"PubChem":["144206084","170465985","26719888","49681761","50112787"],"drugbank":["DB11774"]},"childChemblIds":["CHEMBL3764913"],"count":3,"linkedTargets":{"rows":["ENSG00000131747","ENSG00000077097"],"count":2},"linkedDiseases":{"rows":["EFO_1000829","EFO_0000771","EFO_0004992"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL249530","canonicalSmiles":"Brc1cnn2c(NCc3cccnc3)cc(-c3ccccc3)nc12","inchiKey":"SMIZFGZXFDGISG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL249530","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08535"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL265325","canonicalSmiles":"NC1(C(=O)O)CC1","inchiKey":"PAJPWUMXBYXFCZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"1-Aminocyclopropane carboxylic acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1-Amino-Cyclopropanecarboxylic Acid","1-Aminocyclopropane Carboxylic Acid","1-Aminocyclopropanecarboxylic Acid"],"crossReferences":{"PubChem":["11110708","26749953","26756617","90340879"],"Wikipedia":["1-Aminocyclopropane-1-carboxylic_acid"],"drugbank":["DB02085"],"chEBI":["18053"]},"childChemblIds":["CHEMBL1255660"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL275661","canonicalSmiles":"O=C1CCC(=O)N1","inchiKey":"KZNICNPSHKQLFF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SUCCINIMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Succinimide"],"crossReferences":{"Wikipedia":["Succinimide"],"drugbank":["DB13376"],"chEBI":["9307"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL296419","canonicalSmiles":"COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1","inchiKey":"GXDALQBWZGODGZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ASTEMIZOLE","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"," Malasia"],"classes":["Cardiotoxicity"],"year":1999},"tradeNames":["Hismanal","Pollon-eze"],"synonyms":["Astemizole","GNF-Pf-2461","R 43,512"],"crossReferences":{"PubChem":["104171329","11112828","124882660","124882662","144204231","144207293","170465888","26746979","26751496","26751497","56422418","855746"],"Wikipedia":["Astemizole"],"drugbank":["DB00637"],"chEBI":["2896"]},"childChemblIds":["CHEMBL1788122"],"count":1,"approvedIndications":["EFO_0003785"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0003785"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1988 and is indicated for allergy. It was withdrawn in United States and  Malasia initially in 1999 due to Cardiotoxicity."}
{"id":"CHEMBL304087","canonicalSmiles":"COc1cc(NC(=O)Nc2cccc(CNC(=O)O[C@H]3CCOC3)c2)ccc1-c1cnco1","inchiKey":"JBPUGFODGPKTDW-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MERIMEPODIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Merimepodib","VI-21,497","VI-21497","VX-497"],"crossReferences":{"drugbank":["DB04862"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL305906","canonicalSmiles":"CCCCCCCCCCCCCCCC[n+]1ccccc1","inchiKey":"NEUSVAOJNUQRTM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CETYLPYRIDINIUM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cetylpyridinium"],"crossReferences":{"PubChem":["124890337"],"drugbank":["DB11073"],"chEBI":["32914"]},"childChemblIds":["CHEMBL2003538","CHEMBL34833","CHEMBL1710321","CHEMBL334255"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL3087515","canonicalSmiles":"COC(=O)N1CC[C@@H]2[C@H]1CCC[C@@]2(O)C#Cc1cccc(C)c1","inchiKey":"ZFPZEYHRWGMJCV-ZHALLVOQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MAVOGLURANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AFQ-056","AFQ056","Mavoglurant"],"crossReferences":{"drugbank":["DB13004"]},"count":11,"linkedTargets":{"rows":["ENSG00000168959"],"count":1},"linkedDiseases":{"rows":["EFO_0003948","EFO_0003086","Orphanet_399","EFO_0002610","EFO_0004329","EFO_0002508","EFO_0001421","EFO_0004242","EFO_0004152","EFO_0003829","Orphanet_908"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL3137348","drugType":"Enzyme","blackBoxWarning":false,"name":"SENREBOTASE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AGN-214868","SXN-100323","Senrebotase"],"count":1,"description":"Enzyme drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3137352","drugType":"Antibody","blackBoxWarning":false,"name":"RALPANCIZUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-05335810","RN-317","RN317","Ralpancizumab"],"count":1,"linkedTargets":{"rows":["ENSG00000169174"],"count":1},"linkedDiseases":{"rows":["HP_0003124"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3137669","canonicalSmiles":"CCO.CN1CCC[C@H]1c1cccnc1","inchiKey":"BPDQFGHMIVCAMB-PPHPATTJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3137669","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL314854","canonicalSmiles":"CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1","inchiKey":"KKGQTZUTZRNORY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FINGOLIMOD","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gilenya"],"synonyms":["FTY-720","Fingolimod"],"crossReferences":{"DailyMed":["fingolimod%20hydrochloride"],"Wikipedia":["Fingolimod"],"drugbank":["DB08868"],"chEBI":["63115"]},"childChemblIds":["CHEMBL544665","CHEMBL3526818"],"count":16,"approvedIndications":["EFO_0000540"],"linkedTargets":{"rows":["ENSG00000170989","ENSG00000180739","ENSG00000267534","ENSG00000213694","ENSG00000125910"],"count":5},"linkedDiseases":{"rows":["EFO_1000868","EFO_0007405","EFO_0003929","Orphanet_778","EFO_0000540","EFO_0000305","EFO_0003885","HP_0000083","EFO_1001231","EFO_0003840","HP_0100543","MONDO_0100096","EFO_0008520","EFO_0000270","EFO_0000712","EFO_0000253","EFO_0002499","EFO_0000692","EFO_0000519"],"count":19},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and is indicated for immune system disease and has 15 investigational indications."}
{"id":"CHEMBL3184244","canonicalSmiles":"C[C@H](N)[C@H](O)c1cccc(O)c1.O=C(O)[C@@H](O)[C@@H](O)C(=O)O","inchiKey":"VENXSELNXQXCNT-OHAABKCISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3184244","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1201319","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144204329","170465256"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3187576","canonicalSmiles":"N=C(N)N.N=C(N)N.O=C(O)O","inchiKey":"STIAPHVBRDNOAJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3187576","maximumClinicalTrialPhase":0,"parentId":"CHEMBL821","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["170465438"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL325636","canonicalSmiles":"CCCCCCCCCCCCCC[N+](C)(C)C.[I-]","inchiKey":"AXRFZYRPSHSKBF-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"Trimethyl-tetradecyl-ammonium iodide","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1180003","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Trimethyl-tetradecyl-ammonium iodide"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3301618","canonicalSmiles":"CCCN(CCC)C(=O)C1=Cc2ccc(-c3ccc(C(=O)N4CCCC4)cc3)cc2N=C(N)C1","inchiKey":"QSPOQCXMGPDIHI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOTOLIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Motolimod","VTX-2337","VTX-378"],"crossReferences":{"drugbank":["DB12303"]},"count":9,"linkedTargets":{"rows":["ENSG00000101916"],"count":1},"linkedDiseases":{"rows":["MONDO_0044926","MONDO_0002158","MONDO_0044787","EFO_0002938","EFO_0006352","MONDO_0015686","MONDO_0008170","EFO_0003871","EFO_0000574","EFO_0007535","EFO_0000707","EFO_0000181","EFO_1001967"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL3304485","canonicalSmiles":"CN1Cc2c(Cl)cc(Cl)cc2[C@H](c2cccc(S(=O)(=O)NCCOCCOCCNC(=O)NCCCCNC(=O)NCCOCCOCCNS(=O)(=O)c3cccc([C@@H]4CN(C)Cc5c(Cl)cc(Cl)cc54)c3)c2)C1","inchiKey":"DNHPDWGIXIMXSA-CXNSMIOJSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TENAPANOR","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["AZD-1722","Tenapanor"],"crossReferences":{"DailyMed":["tenapanor%20hydrochloride"],"drugbank":["DB11761"]},"childChemblIds":["CHEMBL3301627"],"count":1,"linkedTargets":{"rows":["ENSG00000066230"],"count":1},"linkedDiseases":{"rows":["EFO_0000555","EFO_0003884","HP_0002905"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2019 and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3341965","canonicalSmiles":"FC(F)(F)c1ccc2c(c1)[C@H]1CNC[C@@H]2C1","inchiKey":"RNOBTWYQAWEZHH-JGVFFNPUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3341965","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12244"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3527055","canonicalSmiles":"COc1ccc(OC(=O)N(CC(=O)O)C[14c]2[14cH][14cH][14c](OCCc3nc(-c4ccccc4)oc3C)[14cH][14cH]2)cc1","inchiKey":"IRLWJILLXJGJTD-BCHNKKCVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3527055","maximumClinicalTrialPhase":0,"parentId":"CHEMBL186179","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL35306","canonicalSmiles":"C[C@@H]([C@H](N)C(=O)N[C@H](C(=O)O)[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@H](O)[C@@H]1O)[C@H](O)c1ccc(O)cn1","inchiKey":"WWJFFVUVFNBJTN-VHDFTHOZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIKKOMYCIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nikkomycin","Nikkomycin Z"],"crossReferences":{"drugbank":["DB12939"],"chEBI":["623918"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3542382","canonicalSmiles":"CC(=O)N1CCN([C@H]2CCN([14C](=O)N(C)[C@H](C)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)[C@@H](c3ccc(F)cc3C)C2)CC1.CS(=O)(=O)O","inchiKey":"YRFKYVWDPCOSTE-MYLQGMGMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3542382","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1672054","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544968","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-610677","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gsk-610677"],"count":1,"linkedTargets":{"rows":["ENSG00000112062"],"count":1},"linkedDiseases":{"rows":["EFO_0000341"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545262","drugType":"Antibody","blackBoxWarning":false,"name":"SACITUZUMAB GOVITECAN","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Trodelvy"],"synonyms":["HRS7-SN38","HRS7-SN38-ANTIBODY-DRUG-CONJUGATE","IMMU-132","Sacituzumab govitecan","Sacituzumab govitecan-hziy"],"crossReferences":{"DailyMed":["sacituzumab%20govitecan-hziy"]},"count":6,"approvedIndications":["EFO_0005537"],"linkedTargets":{"rows":["ENSG00000198900","ENSG00000184292"],"count":2},"linkedDiseases":{"rows":["EFO_0005537","EFO_1001512","EFO_0008528","MONDO_0007254","MONDO_0024880","EFO_0000519","EFO_0003060","MONDO_0008315"],"count":8},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for triple-negative breast cancer and has 5 investigational indications."}
{"id":"CHEMBL356752","canonicalSmiles":"Cc1c(CC(N)=O)c2cc(OCCCC(=O)O)ccc2n1Cc1ccccc1","inchiKey":"STENXUCYNKOBHJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL356752","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02936"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3597971","canonicalSmiles":"Cc1cc(C)nc(N2CC3CN(C(=O)c4c(F)cccc4-n4nccn4)CC3C2)n1","inchiKey":"SQOCEMCKYDVLMM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELTOREXANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JNJ-42847922","MIN-202","Seltorexant"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3707216","canonicalSmiles":"CN(C)c1ccc(O)cc1","inchiKey":"JVVRCYWZTJLJSG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-DIMETHYLAMINOPHENOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-dimethylaminophenol"],"crossReferences":{"drugbank":["DB13549"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707304","canonicalSmiles":"CO[C@@H]1[C@H](C(=O)O)O[C@@H](O[C@@H]2[C@@H](NC(C)=O)[C@H](OC)O[C@H](CO)[C@@H]2OS(=O)(=O)O)[C@H](O)[C@H]1O","inchiKey":"FPJHWYCPAOPVIV-VOZMEZHOSA-N","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"DERMATAN SULFATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dermatan sulfate"],"crossReferences":{"DrugCentral":["2973"]},"count":1,"description":"Oligosaccharide drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707373","canonicalSmiles":"CN[C@H](C)CCC=C(C)C.CN[C@H](C)CCC=C(C)C.O=C(O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)C(=O)O","inchiKey":"WSXKZIDINJKWPM-PPPDGRNVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXISOMETHEPTENE MUCATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL1476245","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dexisometheptene mucate","TNX-201"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL380500","canonicalSmiles":"Nc1nccc(-c2c3c(O)ccnc3n3c(N)nccc23)n1","inchiKey":"RTHKPHCVZVYDFN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VARIOLIN B","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Variolin B"],"crossReferences":{"drugbank":["DB08694"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833354","canonicalSmiles":"NC(=S)NS(=O)(=O)c1ccc(N)cc1.NCc1ccc(S(N)(=O)=O)cc1","inchiKey":"ZLYHTQKHXIVMLY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFATOLAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sulfatolamide","Sulphatolamide"],"crossReferences":{"DrugCentral":["4724"],"drugbank":["DB13547"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL38380","canonicalSmiles":"O=S(=O)(c1cccc2cnccc12)N1CCCNCC1","inchiKey":"NGOGFTYYXHNFQH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FASUDIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AT 877","AT-877","Fasudil","HA 1077","HA-1077","ZK-258594"],"crossReferences":{"PubChem":["103905389","103905390","104171358","11113364","124883255","124883258","124883259","26751605","92708292"],"Wikipedia":["Fasudil"],"drugbank":["DB08162"]},"childChemblIds":["CHEMBL4459126","CHEMBL541388","CHEMBL4435188"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL398440","canonicalSmiles":"Cc1cc(O)cc(C)c1Cl","inchiKey":"OSDLLIBGSJNGJE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOROXYLENOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Chloroxylenol"],"crossReferences":{"PubChem":["11532857","144204858","144212364","170465503","26747913","26753722"],"Wikipedia":["Chloroxylenol"],"drugbank":["DB11121"],"chEBI":["34393"]},"count":1,"approvedIndications":["MP_0001845"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for inflammation."}
{"id":"CHEMBL3989987","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"PATISIRAN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["ALN-18328","ALN-TTR02","Patisiran","SAR-438037"],"count":2,"linkedTargets":{"rows":["ENSG00000118271"],"count":1},"linkedDiseases":{"rows":["EFO_1001875","Orphanet_271861","Orphanet_85447"],"count":3},"description":"Oligonucleotide drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3991241","drugType":"Small molecule","blackBoxWarning":false,"name":"FERRIC CITRATE","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"crossReferences":{"DailyMed":["ferric%20citrate"]},"childChemblIds":["CHEMBL3301597"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2014."}
{"id":"CHEMBL400007","canonicalSmiles":"O=C([O-])C1C/C(=C2/CCN(c3ccccc3)C2=O)c2ccc(Cl)cc2N1.[Na+]","inchiKey":"OKKPHPZRLYFXCK-GEEYTBSJSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL400007","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1207366","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL404630","canonicalSmiles":"Oc1cc(O)c(-c2noc3ccc(NCCN4CCOCC4)cc23)cc1Cl","inchiKey":"JLIRVZVVCCIAKG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL404630","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07601"],"chEBI":["90529"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL410834","canonicalSmiles":"COc1cc2ncnc(N3CC[C@@H](Oc4ccc5ccccc5c4)C3)c2cc1OC","inchiKey":"UPTQSRGSSJRBKJ-LJQANCHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL410834","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08389"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4125998","canonicalSmiles":"[2H]c1nc(-c2cc(NC(=O)c3ccc(S(C)(=O)=O)cc3Cl)ccc2Cl)c([2H])c([2H])c1[2H]","inchiKey":"BPQMGSKTAYIVFO-CKSJCSQYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4125998","maximumClinicalTrialPhase":0,"parentId":"CHEMBL473417","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL425148","canonicalSmiles":"COc1cc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(O)c(OC)c2)ccc1O","inchiKey":"MATGKVZWFZHCLI-LSDHHAIUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MATAIRESINOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-Matairesinol","Matairesinol"],"crossReferences":{"Wikipedia":["Matairesinol"],"drugbank":["DB04200"],"chEBI":["6698"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297065","canonicalSmiles":"CC[C@H]1CCC[C@H](O[C@H]2CC[C@H](N(C)C)[C@@H](C)O2)[C@@H](C)C(=O)C2=C[C@@H]3[C@@H](C=C[C@@H]4C[C@@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]5OC)C[C@@H]34)C2CC(=O)O1.CC[C@H]1CCC[C@H](O[C@H]2CC[C@H](N(C)C)[C@@H](C)O2)[C@@H](C)C(=O)C2=C[C@H]3[C@@H]4C[C@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]5OC)C[C@H]4C(C)=C[C@H]3[C@@H]2CC(=O)O1","inchiKey":"JFLRKDZMHNBDQS-UCQUSYKYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SPINOSAD","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Natroba"],"synonyms":["DE-105","LY-232105","PP-105","Spinosad","Spinosyns spinosad","XDE-105"],"crossReferences":{"DailyMed":["spinosad"]},"count":1,"approvedIndications":["MONDO_0003472"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2011 and is indicated for lice infestation."}
{"id":"CHEMBL4297444","drugType":"Small molecule","blackBoxWarning":false,"name":"TIOMOLIBDATE ION","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tetrathiomolybdate","Tiomolibdate ion"],"count":10,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL4297484","canonicalSmiles":"COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(C#N)c3)CC2)CC1","inchiKey":"PLMAPPWZOQMTBI-XUTJKUGGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BP-14979","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BP-14979","Bp-14979","Bp1.4979"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297488","canonicalSmiles":"CC(C)c1cnn2c(NCc3ccccc3)cc(NC[C@H]3CCNC[C@@H]3O)nc12","inchiKey":"YCVGLKWJKIKVBI-MJGOQNOKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CT-7001","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CT-7001","CT7001","Ct-7001","Ct7001","ICEC-0942","ICEC0942","Samuraciclib"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297496","canonicalSmiles":"CCCCCCCCCCCCCCCCCC(=O)OCC(CSSc1ccc(COC(=O)N2[C@H]3CN4C5=C(C(=O)C(N)=C(C)C5=O)[C@@H](COC(N)=O)[C@@]4(OC)[C@H]32)cc1)OC(=O)CCCCCCCCCCCCCCCCC","inchiKey":"LIHIIWJRSSLKKX-YCTALCSSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"JNJ-27548547","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JNJ-27548547","Jnj-27548547","Promitil"],"crossReferences":{"drugbank":["DB15372"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297518","canonicalSmiles":"CCCOc1ccc(S(=O)(=O)N2CCN(CCO)CC2)cc1-c1nc2c(CCC)cn(CC)c2c(=O)[nH]1","inchiKey":"MIJFNYMSCFYZNY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIRODENAFIL","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mirodenafil","SK-3530 FREE BASE","SK3530 FREE BASE"],"crossReferences":{"drugbank":["DB11792"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297802","drugType":"Enzyme","blackBoxWarning":true,"name":"PEGVALIASE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Palynziq"],"synonyms":["BMN 165","BMN-165","Bmn 165","Pegvaliase","Pegvaliase-pqpz"],"crossReferences":{"DailyMed":["pegvaliase-pqpz"]},"count":1,"approvedIndications":["Orphanet_716"],"description":"Enzyme drug with a maximum clinical trial phase of IV that was first approved in 2018 and is indicated for phenylketonuria. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4298146","canonicalSmiles":"O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O.O=C1CCc2c(Oc3ccc4c(c3)[C@@H]3[C@H](O4)[C@H]3c3nc4cc(C(F)(F)F)ccc4[nH]3)ccnc2N1.O=C1CCc2c(Oc3ccc4c(c3)[C@@H]3[C@H](O4)[C@H]3c3nc4cc(C(F)(F)F)ccc4[nH]3)ccnc2N1","inchiKey":"CETNPISTLYWCDC-CSKNCWRTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LIFIRAFENIB MALEATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL4209157","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BGB-283 sesqui-maleate","Lifirafenib maleate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4300244","drugType":"Small molecule","blackBoxWarning":false,"name":"SAMARIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Samarium"],"childChemblIds":["CHEMBL4297426"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL438139","canonicalSmiles":"COc1ccc([C@@]23Oc4cc(OC)cc(OC)c4[C@]2(O)[C@H](O)[C@H](C(=O)N(C)C)[C@H]3c2ccccc2)cc1","inchiKey":"DAPAQENNNINUPW-IDAMAFBJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROCAGLAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rocaglamide"],"crossReferences":{"PubChem":["458129","92763845"],"drugbank":["DB15495"],"chEBI":["66309"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL446143","canonicalSmiles":"NCCC[C@H](N)C(=O)O","inchiKey":"AHLPHDHHMVZTML-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ORNITHINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ornithine"],"crossReferences":{"Wikipedia":["Ornithine"],"drugbank":["DB00129"],"chEBI":["15729"]},"childChemblIds":["CHEMBL3138616","CHEMBL3184113","CHEMBL4297204"],"count":6,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL44657","canonicalSmiles":"COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O","inchiKey":"VJJPUSNTGOMMGY-MRVIYFEKSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ETOPOSIDE","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Etoposide","Toposar","Vepesid"],"synonyms":["Etoposide","NSC-141540","VP-16-213"],"crossReferences":{"DailyMed":["etoposide"],"PubChem":["164339423","56463308"],"TG-GATEs":["131"],"Wikipedia":["Etoposide"],"drugbank":["DB00773"],"chEBI":["4911"]},"count":128,"approvedIndications":["EFO_0000616","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000131747","ENSG00000077097"],"count":2},"linkedDiseases":{"rows":["EFO_0000637","EFO_0000558","MONDO_0003751","MONDO_0002730","EFO_0005952","EFO_1001052","EFO_0000632","MONDO_0015760","EFO_0000339","EFO_0000096","MONDO_0008903","MONDO_0020574","EFO_0002918","EFO_0000514","EFO_0004991","EFO_1000028","MONDO_0002601","EFO_0000198","MONDO_0013730","EFO_0000221","EFO_0002618","MONDO_0019465","EFO_0000180","EFO_1000574","EFO_1001946","EFO_1001968","EFO_0009538","MONDO_0008315","EFO_0000630","EFO_1001365","EFO_0003028","EFO_0003032","MONDO_0044889","MONDO_0018201","EFO_0009254","EFO_1000527","MONDO_0019472","EFO_0000574","EFO_0004256","EFO_0001378","EFO_1000796","EFO_1000550","MONDO_0015564","MONDO_0018171","EFO_0007416","EFO_0007498","MONDO_0021117","EFO_1001465","MONDO_0007254","Orphanet_790","MONDO_0004095","MONDO_0003541","MONDO_0001056","MONDO_0002158","EFO_1000565","EFO_0004289","EFO_0002499","EFO_0000183","MONDO_0002618","MONDO_0002083","MONDO_0003478","EFO_0000616","EFO_0005088","EFO_0000765","EFO_1001779","Orphanet_59305","MONDO_0024503","MONDO_0019457","EFO_0000403","EFO_0000222","MONDO_0000870","EFO_0003929","MONDO_0021657","EFO_1001471","MONDO_0002120","EFO_0000702","EFO_1001947","MONDO_0002367","MONDO_0018906","MONDO_0019004","MONDO_0024880","MONDO_0000873","EFO_0005543","EFO_0004281","EFO_0000571","MONDO_0000956","EFO_0002426","EFO_0000565","EFO_0000309","EFO_0004251","HP_0001871","EFO_0000182","EFO_0000330","MONDO_0015540","MONDO_0003001","Orphanet_654","EFO_0009441","EFO_0003802","EFO_1000292","EFO_0000220","EFO_0000248","MONDO_0008170","EFO_1000157","EFO_0005842","EFO_0000223","EFO_0002939","EFO_0000502","EFO_0002500","MONDO_0044881","EFO_0003025","MONDO_0100096","MONDO_0000386","MONDO_0021193","MONDO_0044917","EFO_0002428","EFO_0000233","EFO_0000218","EFO_0000563","MONDO_0009348","MONDO_0019471","EFO_0003812","MONDO_0044887","EFO_1001945","EFO_0000209","EFO_1001469","EFO_0000708","MONDO_0016700","MONDO_0002087","MONDO_0016691","EFO_0007362","MONDO_0021364","MONDO_0001475","MONDO_0001657","EFO_0002626","MONDO_0020743","EFO_1000158","EFO_1000415","MONDO_0021656","EFO_0000437","EFO_0000313","EFO_0002501","MONDO_0016717","EFO_0000621","EFO_0003029","EFO_0003060","EFO_0000311","EFO_1001383","EFO_0000211","EFO_1000437","EFO_1000564","EFO_1000581","EFO_0000095","EFO_0000174","EFO_0005235","EFO_0006475","EFO_1001936","EFO_1002008","MONDO_0020077","EFO_0003833","EFO_0000691","EFO_0003027","EFO_0003811"],"count":162},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1983 and is indicated for cancer and neoplasm and has 126 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4560869","canonicalSmiles":"[2H]C([2H])([2H])C([2H])([2H])N1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1","inchiKey":"UZWDCWONPYILKI-RPIBLTHZSA-N","drugType":"unknown","blackBoxWarning":false,"name":"CHEMBL4560869","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3301610","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Unknown drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594230","drugType":"Protein","blackBoxWarning":false,"name":"LIPEGFILGRASTIM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lonquex"],"synonyms":["Lipegfilgrastim","XM-22","XM22"],"count":2,"linkedTargets":{"rows":["ENSG00000119535"],"count":1},"linkedDiseases":{"rows":["EFO_0000174","EFO_0000574"],"count":2},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594499","drugType":"Unknown","blackBoxWarning":false,"name":"SIG12D LODER","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sig12d loder"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594598","drugType":"Unknown","blackBoxWarning":false,"name":"EFTRENONACOG ALFA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIIB-029","Eftrenonacog alfa","Rfixfc"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL469","canonicalSmiles":"O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O","inchiKey":"OZWKMVRBQXNZKK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"KETOROLAC","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ketorolac"],"crossReferences":{"DailyMed":["ketorolac%20tromethamine"],"PubChem":["174007295","90341692"],"Wikipedia":["Ketorolac"],"drugbank":["DB00465"],"chEBI":["76223"]},"childChemblIds":["CHEMBL1201124"],"count":28,"approvedIndications":["EFO_0005752","EFO_0005755"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0003869","EFO_0003777","EFO_1001139","EFO_0004683","EFO_1001178","EFO_0008571","HP_0100790","EFO_0003931","EFO_0002506","EFO_0004253","EFO_0005295","EFO_1000652","EFO_0004616","HP_0003419","EFO_1001250","EFO_0005854","EFO_0005296","HP_0012532","EFO_1000906","EFO_0003821","MONDO_0008170","HP_0000616","EFO_0000546","MP_0001845","EFO_1000859","EFO_0000516","HP_0000540","MONDO_0002258","EFO_0000668","EFO_1001158","EFO_1001434","MONDO_0018373","MONDO_0003005","EFO_0001059","EFO_0000278","HP_0000545","EFO_0008507","MONDO_0007254","MONDO_0002087","MONDO_0002158","EFO_0009444","HP_0002015","EFO_0005752","EFO_0004210","HP_0011110","EFO_0003770","HP_0003418","EFO_0003843","HP_0002315","EFO_0005755","EFO_1001412","HP_0030839","EFO_0010680","EFO_0000649","EFO_0004273","EFO_0003766","EFO_0005611","EFO_0003918"],"count":58},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1989 and is indicated for rheumatic disease and eye inflammation and has 26 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL479789","canonicalSmiles":"N[C@@H](Cc1ccc(O)c(I)c1)C(=O)O","inchiKey":"UQTZMGFTRHFAAM-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOTYROSINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["50104021","855708","90341583"],"Wikipedia":["3-Iodotyrosine"],"drugbank":["DB01758"],"chEBI":["27847"]},"childChemblIds":["CHEMBL2107690"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL480626","canonicalSmiles":"CC(C)(C)c1cc(O)c(C(C)(C)C)cc1O","inchiKey":"JZODKRWQWUWGCD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Di-Tert-Butylhydroquinone","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Di-Tert-Butylhydroquinone"],"crossReferences":{"PubChem":["11113984","144210703","26752127","47193730"],"drugbank":["DB04638"],"chEBI":["41094"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL501","canonicalSmiles":"CC(N)Cc1ccccc1.O=S(=O)(O)O","inchiKey":"SOFQDLYSFOWTJX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"AMPHETAMINE SULFATE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL405","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amphetamine sulfate","Benzadrine","Evekeo","Evekeo odt"],"synonyms":["Amfetamine sulfate","Amphetamine Sulfate","Amphetamine sulfate","NSC-170999"],"crossReferences":{"DailyMed":["amphetamine%20sulfate"]},"count":3,"approvedIndications":["EFO_0003888","EFO_0000614"],"linkedTargets":{"rows":["ENSG00000103546","ENSG00000142319"],"count":2},"linkedDiseases":{"rows":["EFO_0003888","EFO_0002610","EFO_0000614"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1960 and is indicated for narcolepsy with cataplexy and attention deficit hyperactivity disorder and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL505","canonicalSmiles":"CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1","inchiKey":"SOYKEARSMXGVTM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORPHENIRAMINE","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Antagonate","Chlor-Trimeton","Chlorphenamine","Chlorpheniramine","Isoclor","Kloromin","Phenetron","Teldrin"],"crossReferences":{"DailyMed":["chlorpheniramine%20maleate"],"PubChem":["174006626","174007153","50110994","90340572"],"TG-GATEs":["90"],"Wikipedia":["Chlorphenamine"],"drugbank":["DB01114"],"chEBI":["52010"]},"childChemblIds":["CHEMBL1201659","CHEMBL180454","CHEMBL1659"],"count":5,"approvedIndications":["EFO_0003785"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0007486","HP_0012735","EFO_0000270","EFO_0003958","EFO_0007328","EFO_0003785","EFO_0003956","EFO_0004239"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1950 and is indicated for allergy and has 4 investigational indications."}
{"id":"CHEMBL506649","canonicalSmiles":"CCCC[C@H](CN(O)C=O)C(=O)N1CCC[C@H]1c1nc2ccccc2o1","inchiKey":"QDDZLTVSNABZIK-ZBFHGGJFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL506649","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08310"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL508112","canonicalSmiles":"c1ccc2sc(SSc3nc4ccccc4s3)nc2c1","inchiKey":"AFZSMODLJJCVPP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZOTHIAZYL DISULFIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BI-87F4"],"crossReferences":{"PubChem":["144204657","170465723","17390019","26752944"],"drugbank":["DB14201"],"chEBI":["53239"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL509485","canonicalSmiles":"CNS(=O)(=O)c1ccc(Nc2ncc(C(F)(F)F)c(N[C@@H]3CCC[C@H]3N(C)C)n2)cc1","inchiKey":"CAUFYHKGKDJMQG-HZPDHXFCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL509485","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08341"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL518051","canonicalSmiles":"CS(=O)(=O)O.O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1","inchiKey":"FYCODPVDEFFWSR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SNS-314","maximumClinicalTrialPhase":0,"parentId":"CHEMBL482767","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SNS-314"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL542653","canonicalSmiles":"CC(C)(N)C(=O)N[C@H](COCc1ccccc1)C(=O)N1CCC2(CC1)CN(S(C)(=O)=O)c1ccccc12.Cl","inchiKey":"MHSYJMYLVYEDSA-VZYDHVRKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL542653","maximumClinicalTrialPhase":0,"parentId":"CHEMBL13817","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL544665","canonicalSmiles":"CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1.Cl","inchiKey":"SWZTYAVBMYWFGS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FINGOLIMOD HYDROCHLORIDE","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL314854","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gilenya"],"synonyms":["FTY-720 HYDROCHLORIDE","FTY720","FTY720 HYDROCHLORIDE","Fingolimod","Fingolimod hydrochloride"],"crossReferences":{"DailyMed":["fingolimod%20hydrochloride"],"chEBI":["63112"]},"count":4,"approvedIndications":["EFO_0003885"],"linkedTargets":{"rows":["ENSG00000170989","ENSG00000180739","ENSG00000267534","ENSG00000213694","ENSG00000125910"],"count":5},"linkedDiseases":{"rows":["EFO_0003885","EFO_0003929","EFO_0000253","EFO_0000305"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and is indicated for multiple sclerosis and has 3 investigational indications."}
{"id":"CHEMBL556954","canonicalSmiles":"Cl.Cl.c1cnc2cc3c(cc2n1)C1CNCC3C1","inchiKey":"NZVVYNGXLGJKCW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL556954","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1396","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL56053","canonicalSmiles":"CC[C@@H](C)[C@H](N)C(=O)O","inchiKey":"AGPKZVBTJJNPAG-UHNVWZDZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL56053","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205857"],"drugbank":["DB01739"],"chEBI":["43433"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL56190","canonicalSmiles":"CNc1nc(N)[nH]c(=O)c1[N+](=O)[O-]","inchiKey":"NMCMUSAXKISTKW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL56190","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03705"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL570537","canonicalSmiles":"CC(C)(C)Nc1nc(N)c(C(=O)c2ccccc2)s1","inchiKey":"KEHNGAHNKVLUSC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL570537","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08778"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL583","canonicalSmiles":"Cc1c(F)c(N2CCNC(C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1","inchiKey":"AIJTTZAVMXIJGM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GREPAFLOXACIN","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"," United Kingdom"," United States"," Germany"],"classes":["Cardiotoxicity"],"year":1999},"tradeNames":[],"synonyms":["Grepafloxacin","Raxar"],"crossReferences":{"PubChem":["50112780"],"Wikipedia":["Grepafloxacin"],"drugbank":["DB00365"],"chEBI":["5543"]},"childChemblIds":["CHEMBL1200393"],"count":2,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for bacterial disease and has 1 investigational indication. It was withdrawn in United States,  United Kingdom,  United States and  Germany initially in 1999 due to Cardiotoxicity."}
{"id":"CHEMBL592445","canonicalSmiles":"CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1","inchiKey":"DWZAEMINVBZMHQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GEDATOLISIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gedatolisib","PF-05212384","PKI-587"],"crossReferences":{"drugbank":["DB11896"]},"count":8,"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000117461","ENSG00000198793"],"count":9},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","EFO_1001480","EFO_0005537","MONDO_0007254","EFO_0000222","EFO_0004230","EFO_0003060","EFO_0000311"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL593","canonicalSmiles":"CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1","inchiKey":"WHBIGIKBNXZKFE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DELAVIRDINE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Delavirdine","U-90152"],"crossReferences":{"PubChem":["144206190","170464664"],"Wikipedia":["Delavirdine"],"drugbank":["DB00705"],"chEBI":["119573"]},"childChemblIds":["CHEMBL929"],"count":2,"approvedIndications":["EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for viral disease and has 1 investigational indication."}
{"id":"CHEMBL61479","canonicalSmiles":"Fc1ccc(-n2cc(CCCCN3CCC4(CC3)OCc3ccccc34)c3ccccc32)cc1","inchiKey":"XWAONOGAGZNUSF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SIRAMESINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Siramesine"],"crossReferences":{"drugbank":["DB06555"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL62382","canonicalSmiles":"C[Se]C[C@H](N)C(=O)O","inchiKey":"XDSSPSLGNGIIHP-VKHMYHEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLSELENOCYSTEINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Methylselenocysteine","Se-Methylselenocysteine"],"crossReferences":{"PubChem":["90341483"],"drugbank":["DB12697"],"chEBI":["27812"]},"childChemblIds":["CHEMBL1256174"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL63857","canonicalSmiles":"O=C1OC(c2ccc(O)cc2)(c2ccc(O)cc2)c2ccccc21","inchiKey":"KJFMBFZCATUALV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENOLPHTHALEIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alophen","Ex-lax","Prulet"],"synonyms":["Phenolphthalein"],"crossReferences":{"PubChem":["104171370","124883460","144204389","144209417","144210602","170465559","17389766","26747045","26747046","26751565","50100917","50104178","56422367","855935"],"Wikipedia":["Phenolphthalein"],"drugbank":["DB04824"],"chEBI":["34914"]},"count":1,"approvedIndications":["HP_0002019"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for constipation."}
{"id":"CHEMBL648","canonicalSmiles":"CN1CCN(C(c2ccccc2)c2ccccc2)CC1","inchiKey":"UVKZSORBKUEBAZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLIZINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cyclizine","Marezine"],"crossReferences":{"PubChem":["11112316","124882239","26747952"],"Wikipedia":["Cyclizine"],"drugbank":["DB01176"],"chEBI":["3994"]},"childChemblIds":["CHEMBL1324714","CHEMBL3189137","CHEMBL1200497"],"count":1,"approvedIndications":["EFO_0003785"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0003785"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for allergy."}
{"id":"CHEMBL68828","canonicalSmiles":"C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)OCc1ccccc1)C(=O)CF","inchiKey":"RYABQRLJLIHDIP-KSSFIOAISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL68828","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08775"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL74078","canonicalSmiles":"O=C(O)c1ccc(-c2cc3cccnc3c(-c3cccc([N+](=O)[O-])c3)n2)cc1","inchiKey":"QTNUWEKKZHSUQO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL74078","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08299"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL74926","canonicalSmiles":"CN1CC[C@@]2(C)c3cc(OC(=O)Nc4ccccc4)ccc3N(C)[C@@H]12","inchiKey":"PBHFNBQPZCRWQP-QUCCMNQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENSERINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phenserine"],"crossReferences":{"PubChem":["26756608","90341153"],"drugbank":["DB04892"]},"childChemblIds":["CHEMBL123249"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL761","canonicalSmiles":"c1ccc2c(CC3=NCCN3)cccc2c1","inchiKey":"CNIIGCLFLJGOGP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAPHAZOLINE","yearOfFirstApproval":1971,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Nafazair","Naphazoline"],"crossReferences":{"DailyMed":["naphazoline%20hydrochloride"],"PubChem":["11112411","26751615"],"Wikipedia":["Naphazoline"],"drugbank":["DB06711"]},"childChemblIds":["CHEMBL1706"],"count":6,"approvedIndications":["EFO_0005751","HP_0001742"],"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000150594"],"count":6},"linkedDiseases":{"rows":["EFO_0000616","MP_0001845","EFO_0000678","EFO_0007328","EFO_0005751","EFO_0007141","HP_0001742","EFO_0007214"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1971 and is indicated for nasal obstruction and eye allergy and has 4 investigational indications."}
{"id":"CHEMBL878","canonicalSmiles":"Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C","inchiKey":"AQCHWTWZEMGIFD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METOLAZONE","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Diulo","Metenix","Metolazone","Mykrox","Xuret","Zaroxolyn"],"synonyms":["Metolazone","SR 720-22","SR-720-22"],"crossReferences":{"DailyMed":["metolazone"],"PubChem":["144203737","144207075","170464665","26747536","26747537","26753589","26753590","56463247"],"Wikipedia":["Metolazone"],"drugbank":["DB00524"],"chEBI":["64354"]},"count":3,"approvedIndications":["EFO_0003144","EFO_0000373","EFO_0000319"],"linkedTargets":{"rows":["ENSG00000070915"],"count":1},"linkedDiseases":{"rows":["HP_0012664","EFO_0003144","EFO_0003884","EFO_0000373","EFO_0000319"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1973 and has 3 approved indications."}
{"id":"CHEMBL969","canonicalSmiles":"O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC1CC1","inchiKey":"MWQCHHACWWAQLJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRAZEPAM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Centrax","Demetrin","Prazepam"],"synonyms":["Prazepam","W 4020","W-4020"],"crossReferences":{"PubChem":["144206168","144207274","50113069"],"Wikipedia":["Prazepam"],"drugbank":["DB01588"],"chEBI":["8362"]},"count":1,"approvedIndications":["EFO_0005230"],"linkedTargets":{"rows":["ENSG00000182256","ENSG00000022355","ENSG00000011677","ENSG00000163285","ENSG00000151834","ENSG00000113327","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["EFO_0005230"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for anxiety."}
{"id":"CHEMBL989","canonicalSmiles":"CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1","inchiKey":"FEBLZLNTKCEFIT-VSXGLTOVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUOCINOLONE ACETONIDE","yearOfFirstApproval":1963,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Capex","Derma-smoothe/fs","Dermotic","Fluocet","Fluocinolone acetonide","Fluonid","Fluotrex","Fs shampoo","Iluvien","Retisert","Synalar","Synalar fte","Synalar-c","Synalar-hp","Synalar-n","Synandone","Yutiq"],"synonyms":["Fluocinolone","Fluocinolone acetonide","NSC-92339"],"crossReferences":{"DailyMed":["fluocinolone%20acetonide"],"PubChem":["144204420","144212681","170464630","29214997","398387","56422130","855535"],"Wikipedia":["Fluocinolone_acetonide"],"drugbank":["DB00591"],"chEBI":["31623"]},"count":8,"approvedIndications":["EFO_0003963","EFO_0009552","EFO_0005752"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0009606","EFO_1001231","EFO_1001494","EFO_0009560","EFO_0001365","EFO_0003963","MONDO_0021666","EFO_0003839","EFO_0009552","EFO_0009321","EFO_0005752","EFO_1001119","EFO_0003785"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1963 and has 3 approved and 5 investigational indications."}
